Nimesulide for joint painrelief: January 2016

Friday, January 22, 2016

Nimesulide forms

Nimesulide tablet is indicated for the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old with with analgesic and antipyretic properties.

Nimesulide is available in the form of tablets, powder for dissolution in water, suppositories, mouth dissolving tablets and topical gel.

Nimesulide dosage is of 100 mg for the tablets, and100 mg for granules for oral suspension, 200mg for the suppositories and 3% of gel.

Nimesulide has superior gastrointestinal safety as compared to other NSAIDs with multi factorial approach for treating post-traumatic inflammation, acute musculoskeletal disorders including sprains, strains, tendinitis, tenosynovitis, low back pain, periarthritis (shoulder pain) and osteoarthritis (joint pains), stiffness.

It was launched in Italy for the first time as Aulin and Mesulid in 1985 and is presently available in more than 50 countries worldwide in different trademarks Its multifactorial mode of action gives it a unique and broad action on inflammatory processes.

The maximum duration prescribed for the tablet is 15 days and the dosage to be used is 100 Mgs.

Monday, January 18, 2016

Nimesulide Uses

Nimesuilde is a pain killer NSAIDs drug best prescribed drug for treatment of acute pain, Primary dysmennorhea and also to treat degenerative joint disease.

Nimesulide is indicated in the treatment of a variety of painful inflammatory conditions including those associated with Osteoarthritis, Postoperative trauma, Sports injuries, Ear, Nose and Throat disorders, Dental surgery, Bursitis/Tendinitis, Thrombhophlebitis, Pharyngitis and Gynaecological disorders.

Nimesulide is a prescription drug with important analgesic properties. Therefore it is always recommended to use this medicine under a licensed physician supervision and as per approved indications.

Nimesulide Tablet is also used for:

Rapid onset of action within 15 minutes
Nimesulide has less gastrointestinal adverse effects than other NSAIDs

Nimesulide Uses

Rapid onset of action within 15 minutes
Nimesulide has less gastrointestinal adverse effects than other NSAIDs.

Nimesulide Uses

Rapid onset of action within 15 minutes
Nimesulide has less gastrointestinal adverse effects than other NSAIDs.

Nimesulide Uses

Rapid onset of action within 15 minutes
Nimesulide has less gastrointestinal adverse effects than other NSAIDs.

Nimesulide Gel

Nimesulide is available in various forms including tablets, suppositories, water-soluble powders, and topical gels.

Nimesulide Gel (Nimesulide/Methyl Salicylate/Menthol/Capsaicin) is used to treat chronic and acute musculoskeletal disorders such as soft tissue injuries or non-articular rheumatic disorders, including discomfort in the muscles, tendonitis, back pain/ache, arthritis, tenosynovitis sprains, or strains.

Nimesulide is used topically as an analgesic with NSAID benefits and functions by inhibiting particular nerve impulses sent from the periphery to your central system, leading to a decrease of sensitivity from the kinds of symptoms.

Dosage and Administration

Nimesulide Gel is apply to the affected area, rubbing in a thin layer of the gel 2 to 4 times every day. For best results, wash the application area beforehand to clean away any oil, grease, or bacteria, allowing the gel to absorb more easily.

Nimesulide is available in assortment of structures like as tablets and syrup for oral organization and gels for topical application.

The anti-inflammatory activity of topically applied Nimesulide gel demonstrations particularly on cyclo-oxygenase-2 which applies less gastrointestinal antagonistic impacts than different NSAIDs.

Nimesulide Tablet Indication

Anti-inflammatory Analgesics tablet – Nimesulide is required for the quick treatment of severe muscular pains and inflammatory problems. Nimesulide tablets is available in different countries in the world.

Nimesulide is Indicated in reducing pain, fever and inflammatory symptoms of:

Chronic arthritis
Osteo arthritis
Otorhinolary diseases
Soft tissues and oral cavity inflammation
Dysmenorrhoea
Thrombosis
Urogenital disease
Postoperative pain states
Sports injuries

Uses of Nimesulide:

Rapid onset of action within 15 minutes
Rapidly relieves pain in arthritis

Nimesulide Tablet Indication

Chronic arthritis
Osteo arthritis
Otorhinolary diseases
Soft tissues and oral cavity inflammation
Dysmenorrhoea
Thrombosis
Urogenital disease
Postoperative pain states
Sports injuries

Uses of Nimesulide:

Rapid onset of action within 15 minutes
Rapidly relieves pain in arthritis

Sunday, January 17, 2016

Nimesulide medicine for osteoarthritis

Nimesulide drug was launched in Italy for the first time as Aulin and Mesulid in 1985 and is presently available in more than 50 countries worldwide with different trademarks.

Nimesulide is used for the treatment of post-traumatic inflammation, acute musculoskeletal disorders including sprains, strains, tendinitis, tenosynovitis, low back pain, periarthritis (shoulder pain) and osteoarthritis (joint pains), stiffness.

Nimesulide brands such as Sulide, Nimalox, Nimesil, Nimulid, Nicip, Nimcap, Nise, Sulidene and Zolan.

It has superior gastrointestinal safety as compared to other NSAIDs.

It is an analgesic and antipyretic in action. Its multifactorial mode of action gives it a unique and broad action on inflammatory processes.

The maximum duration and dose of a treatment course with Nimesulide medicine is 15 days, 100 mg twice a day, to minimize the risk of hepatotoxicity.

Nimesulide also improves the skin tone and to increase in energy levels. Food, gender and advanced age have negligible effects on Nimesulide pharmacokinetics.

Unlike, other NSAIDs, the chemical structure of nimesulide does not contain a carboxylic group but a sulfonanilide moiety as the acidic group.

It undergoes extensive biotransformation and has a relatively rapid onset of action, with meaningful reductions in pain and inflammation observed within 15 minutes from drug intake.